semaglutidesurvodutidetirzepatide
…, whereby researchers are investigating the use of subcutaneous semaglutide 2.4 mg/week for the treatment of adults with non-cirrhotic MASH…
2articles mentioning drugs
3drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: pegozafermin ×
pegozafermin
This drug is selected. Its supporting articles are shown below.
Articles mentioning pegozafermin
2 articles · page 1 of 1PGZPegozaferminT2DMMASHF2/F3 fibrosisobesity
… a subset of placebo patients who were re-randomized to receive PGZ 30mg QW. The full analysis set includes patients who were F2-F3…